Antibody Drug Conjugation (ADC)

Discover BiCell's pioneering range of antibody-drug conjugates (ADCs), a cornerstone of modern targeted cancer therapy. Our online shop offers an extensive selection of ADCs, meticulously designed to deliver potent anticancer agents directly to tumor cells, minimizing harm to healthy tissues. Each product embodies our commitment to advancing cancer treatment, supported by cutting-edge research and rigorous quality standards.

Our Products: Precision Meets Efficacy

At BiCell, we understand the complexities of cancer and the need for precise, effective treatments. Our ADCs are engineered for specificity, targeting cancer cells with unparalleled accuracy. Browse our catalog to find ADCs for various research and therapeutic applications, including but not limited to:

• Breast Cancer
• Lung Cancer
• Leukemia
• Lymphoma
• Solid Tumors

Each product page provides detailed information, including target antigens, drug-to-antibody ratio (DAR), and therapeutic indications, ensuring you find the perfect match for your research or clinical needs.

Quality You Can Trust

Quality and reliability are the bedrock of our operations. BiCell's ADCs are produced in state-of-the-art facilities, adhering to the highest standards of purity, stability, and activity. Rigorous testing and validation processes guarantee that our products meet and exceed global regulatory requirements, providing you with ADCs you can trust for your critical research and treatment endeavors.

Expert Support and Resources

At BiCell, we're not just about selling products; we're about building partnerships in the fight against Cancer. Our team of experts is available to provide technical support, advice on product selection, and assistance with protocol optimization. Additionally, our website offers a wealth of resources, including research articles, case studies, and application guides, to support your work at every step.